載入...
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis
While death receptor ligands (Fas and TRAIL) kill chemoresistant tumor cell lines, related therapies have limited clinical efficacy as single agents. Death receptor signaling is modulated by nuclear factor-κB (NFκB), a family of transcription factors which are constitutively active in B-cell maligna...
Na minha lista:
發表在: | Oncotarget |
---|---|
Main Authors: | , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Impact Journals LLC
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400571/ https://ncbi.nlm.nih.gov/pubmed/28177892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15050 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|